PCI Synthesis

35 articles with PCI Synthesis

• PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2019

  12/11/2018

  PCI Synthesis, Inc. (www.pcisynthesis.com), issued its annual list of trends that will affect the emerging biotech and generic drug sectors, as well as Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) in 2019.

• Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

  6/20/2018

  Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis

• PCI Synthesis Submits Patent for Synthesizing Azelaic Acid

  1/30/2018

  Azelaic Acid is used for producing industrial products including polyesters, plasticizers and lubricants and is a component in skin-care products.

• PCI Synthesis’ Ed Price Joins SOCMA’s Board of Governors

  1/11/2018

  Price, who has been involved in a number of other industry associations over more than two decades, was elected to the board during SOCMA’s 96th Annual Business Meeting on December 4, 2017, in New York.

• PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018

  12/18/2017

  PCI Synthesi issued its annual list of trends that will affect the emerging biotech and generic drug sectors, as well as CDMOs, CROs and CMOs in 2018.

• Scott Vanderwel Joins PCI Synthesis as Business Development Manager Opens San Diego Office to Better Serve West Coast Emerging Pharma Sector

  11/16/2017

  VanderWel will lead sales and marketing efforts for the West Coast.

• Scott VanderWel Joins PCI Synthesis as Business Development Manager

  11/15/2017

  VanderWel will lead sales and marketing efforts for the West Coast.

• PCI Synthesis Wins Big At 2017 Life Science Leader Magazine CMO Leadership Awards

  3/23/2017

• PCI Synthesis Picks Up Life Science CMO Leaderships Awards In All Six Categories

  2/1/2017

• PCI Synthesis Identifies Trends Affecting The Generic Drugs Sector In 2017

  12/19/2016

• PCI Synthesis Obtains DEA Registration For Controlled Substance Development And Manufacturing

  9/15/2016

• PCI Synthesis Announces The Addition Of Its cGMP Advanced Polymer Development And Manufacturing Group

  4/21/2016

• PCI Synthesis Announces The Addition Of Its cGMP Advanced Polymer Development And Manufacturing Group

  4/20/2016

• PCI Synthesis Picks Up Two Life Science Leader Awards

  2/9/2016

• PCI Synthesis Deepens Connections With The Greater Boston Life Sciences Community With The Signing Of A Dozen Local Biotech Customers

  6/12/2015

• PCI Synthesis Earns Top Life Science Leader Awards For The Second Year In A Row

  3/16/2015

• PCI Synthesis Sponsors New England CRO/CMO Council

  12/17/2014

• PCI Synthesis Announces 2015 Trends And Predictions

  12/12/2014

• PCI Synthesis Co-Sponsors Third Annual Massachusetts CRO/CMO Symposium

  4/22/2014

• PCI Synthesis To Pick Up Four 2013 CMO Leadership Awards

  3/11/2014